{"id":"W1488386819","doi":"10.1002/cncr.28766","title":"Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality‐of‐life assessments","year":2014,"lang":"en","type":"article","venue":"Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Axitinib; Thyroid cancer; Internal medicine; Cancer; Adverse effect; Pharmacodynamics; Population; Quality of life (healthcare); Medullary thyroid cancer; Clinical endpoint; Pharmacokinetics; Clinical trial; Oncology; Sunitinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008361355,0.0003296502,0.0008577759,0.00009032491,0.00004998802,0.000008548167,0.00006803107,0.00003412181,0.000218205],"category_scores_gemma":[0.000005811608,0.0002074382,0.00006516508,0.000212758,0.0001478462,0.00007995647,0.00001825845,0.00007398589,9.327143e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002563181,"about_ca_system_score_gemma":0.0003067123,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001440889,"about_ca_topic_score_gemma":0.0004675728,"domain_scores_codex":[0.9983261,0.00008742957,0.000431404,0.0004657041,0.0004100252,0.0002792976],"domain_scores_gemma":[0.998755,0.00009348275,0.0003706591,0.0003309388,0.0001966432,0.000253264],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01604293,0.0098195,0.7201607,0.0005362493,0.003292046,0.00003251534,0.001342776,0.0008145442,0.04209944,0.00008131653,0.000100388,0.2056776],"study_design_scores_gemma":[0.2529498,0.07084636,0.5660111,0.000899201,0.00517771,0.00001650507,0.002222243,0.0009341878,0.0918187,0.000008595374,0.008209703,0.0009059454],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896101,0.007573354,0.00008034983,0.0003316579,0.0001095571,0.001563099,0.0001808869,0.00003457532,0.0005164706],"genre_scores_gemma":[0.9928577,0.004803758,0.0003194858,0.0001632047,0.0001239448,0.001402005,0.00002016381,0.0000509894,0.0002587682],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2369069,"threshold_uncertainty_score":0.8459084,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03737203276533978,"score_gpt":0.4206336851554701,"score_spread":0.3832616523901303,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}